Skip to main content
Print Save

AN 322 (Niacin Extended-Release 750 mg)

Pill with imprint AN 322 is Orange, Capsule-shape and has been identified as Niacin Extended-Release 750 mg. It is supplied by Amneal Pharmaceuticals of New York, LLC.

Niacin is used in the treatment of high cholesterol; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia; niacin deficiency; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug classes miscellaneous antihyperlipidemic agents, vitamins. Risk cannot be ruled out during pregnancy. Niacin 750 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AN 322

Niacin extended-release 750 mg AN 322
Niacin extended-release 750 mg AN 322
Niacin extended-release 750 mg AN 322

Niacin Extended-Release

Imprint
AN 322
Strength
750 mg
Color
Orange
Size
19.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Miscellaneous antihyperlipidemic agents, Vitamins
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals of New York, LLC
Inactive Ingredients
FD&C Yellow No. 6, hydroxyethyl cellulose (4000 mpa.s at 1%), hypromelloses, polyethylene glycol, ferric oxide red, stearic acid, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
65162-0322 Amneal Pharmaceuticals LLC
10135-0613 Marlex Pharmaceuticals Inc.
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Related images for "AN 322"

Pill Lannett 1782 250 mg White Capsule-shape is Temozolomide
Temozolomide
Pill ANI 822 White Capsule-shape is Mexiletine Hydrochloride
Mexiletine Hydrochloride

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer